{"ORPHApacket":[{"ORPHApacketID":"364033","date":"2019-12-06 04:04:55","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"364033","Name":[{"lang":"en","label":"Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_364033","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"T-cell non-Hodgkin lymphoma"}],"ORPHA":"171918","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_171918"},{"Name":[{"lang":"en","label":"Epstein-Barr virus-associated malignant lymphoproliferative disorder"}],"ORPHA":"289644","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_289644"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A rare and very aggressive neoplastic disease emerging after a primary acute or chronic active EBV infection. It presents with persisting fever and malaise, hepatosplenomegaly with or without lymphadenopathy, liver failure, severe pancytopenia and a rapid progression towards multi-organ failure and hemophagocytic syndrome with a fatal issue. It is characterized by clonal proliferation of EBV-infected T cells with an activated cytotoxic phenotype."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"2","Synonym":[{"lang":"en","label":"Systemic EBV+ T-cell LPD of childhood"},{"lang":"en","label":"Systemic EBV-positive T-cell lymphoproliferative disease of childhood"}]}]}]}